Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation.
about
Clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.Artificial Organs 2013: a year in review.Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report
P2860
Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Anticoagulation with fondapari ...... g study and safety evaluation.
@ast
Anticoagulation with fondapari ...... g study and safety evaluation.
@en
type
label
Anticoagulation with fondapari ...... g study and safety evaluation.
@ast
Anticoagulation with fondapari ...... g study and safety evaluation.
@en
prefLabel
Anticoagulation with fondapari ...... g study and safety evaluation.
@ast
Anticoagulation with fondapari ...... g study and safety evaluation.
@en
P2093
P2860
P356
P1433
P1476
Anticoagulation with fondapari ...... g study and safety evaluation.
@en
P2093
Anne-Marie Bogaert
Elien Mahieu
Karel Op De Beek
Kathleen Claes
Marc Jacquemin
Peter Verhamme
Pieter Evenepoel
P2860
P304
P356
10.1111/AOR.12002
P577
2013-03-05T00:00:00Z